These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 1729280)

  • 1. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
    Roodman GD; Kurihara N; Ohsaki Y; Kukita A; Hosking D; Demulder A; Smith JF; Singer FR
    J Clin Invest; 1992 Jan; 89(1):46-52. PubMed ID: 1729280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast function in Paget's disease and multiple myeloma.
    Roodman GD
    Bone; 1995 Aug; 17(2 Suppl):57S-61S. PubMed ID: 8579899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.
    Kukita A; Chenu C; McManus LM; Mundy GR; Roodman GD
    J Clin Invest; 1990 Apr; 85(4):1280-6. PubMed ID: 2318982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
    Neale SD; Smith R; Wass JA; Athanasou NA
    Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell biology of Paget's disease.
    Reddy SV; Menaa C; Singer FR; Demulder A; Roodman GD
    J Bone Miner Res; 1999 Oct; 14 Suppl 2():3-8. PubMed ID: 10510206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
    Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
    J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens.
    Mills BG; Frausto A; Singer FR; Ohsaki Y; Demulder A; Roodman GD
    Bone; 1994; 15(4):443-8. PubMed ID: 7917585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
    Hoyland JA; Freemont AJ; Sharpe PT
    J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease.
    Demulder A; Takahashi S; Singer FR; Hosking DJ; Roodman GD
    Endocrinology; 1993 Nov; 133(5):1978-82. PubMed ID: 7691583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone.
    Naot D; Bava U; Matthews B; Callon KE; Gamble GD; Black M; Song S; Pitto RP; Cundy T; Cornish J; Reid IR
    J Bone Miner Res; 2007 Feb; 22(2):298-309. PubMed ID: 17129176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
    Reddy SV; Kurihara N; Menaa C; Landucci G; Forthal D; Koop BA; Windle JJ; Roodman GD
    Endocrinology; 2001 Jul; 142(7):2898-905. PubMed ID: 11416009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
    Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
    J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
    Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
    J Bone Miner Res; 2006 Mar; 21(3):446-55. PubMed ID: 16491293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.
    Kurihara N; Reddy SV; Araki N; Ishizuka S; Ozono K; Cornish J; Cundy T; Singer FR; Roodman GD
    J Bone Miner Res; 2004 Jul; 19(7):1154-64. PubMed ID: 15176999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
    Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
    J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease.
    Neale SD; Schulze E; Smith R; Athanasou NA
    QJM; 2002 Apr; 95(4):233-40. PubMed ID: 11937650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption.
    Takahashi S; Reddy SV; Chirgwin JM; Devlin R; Haipek C; Anderson J; Roodman GD
    J Biol Chem; 1994 Nov; 269(46):28696-701. PubMed ID: 7961821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.
    Sambandam Y; Sundaram K; Saigusa T; Balasubramanian S; Reddy SV
    Bone; 2017 Aug; 101():236-244. PubMed ID: 28506889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paget's disease and osteoclast biology.
    Roodman GD
    Bone; 1996 Sep; 19(3):209-12. PubMed ID: 8873960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.